UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation

Annals of oncology, 2010-11, Vol.21 (11), p.2294-2295

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

Journal of medical genetics, 2010-09, Vol.47 (9), p.623-630

2010

Link zum Volltext

Verfügbarkeit prüfen

The putative oncogene CPI-17 is up-regulated in schwannoma

Neuropathology and applied neurobiology, 2016-12, Vol.42 (7), p.664-668

2016

Link zum Volltext

Verfügbarkeit prüfen

Growth in neurofibromatosis 1 microdeletion patients

Clinical genetics, 2016-03, Vol.89 (3), p.351-354

2016

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic criteria for schwannomatosis

Neurology, 2005-06, Vol.64 (11), p.1838

2005

Link zum Volltext

Verfügbarkeit prüfen

High Frequency of Mosaicism among Patients with Neurofibromatosis Type 1 (NF1) with Microdeletions Caused by Somatic Recombination of the JJAZ1 Gene

American journal of human genetics, 2004-09, Vol.75 (3), p.410-423

2004

Link zum Volltext

Verfügbarkeit prüfen

Malignant Peripheral Nerve Sheath Tumors (MPNST) in NF1-affected Children

Anticancer research, 2007-07, Vol.27 (4A), p.1957-1960

2007

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1

Journal of medical genetics, 2006-10, Vol.43 (10), p.810-813

2006

Link zum Volltext

Verfügbarkeit prüfen

Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2015-12, Vol.187 (12), p.1084

2015

Link zum Volltext

Verfügbarkeit prüfen

Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)

Journal of medical genetics, 2009-04, Vol.46 (4), p.259-265

2009

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas

Journal of medical genetics, 2009-02, Vol.46 (2), p.81-85

2009

Link zum Volltext

Verfügbarkeit prüfen

High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1

Osteoporosis international, 2010, Vol.21 (1), p.119-127

2010

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy

Journal of neurology, 2013, Vol.260 (1), p.38-46

2013

Link zum Volltext

Verfügbarkeit prüfen

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

Gene therapy, 2004-08, Vol.11 (16), p.1256-1263

2004

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

Acta neurologica Scandinavica, 2016-06, Vol.133 (6), p.475-480

2016

Link zum Volltext

Verfügbarkeit prüfen

CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice

Phytotherapy research, 2009-02, Vol.23 (2), p.226-230

2009

Link zum Volltext

Verfügbarkeit prüfen

Cardiac characterization of 16 patients with large NF1 gene deletions

Clinical genetics, 2013-10, Vol.84 (4), p.344-349

2013

Link zum Volltext

Verfügbarkeit prüfen

Elevated Risk for MPNST in NF1 Microdeletion Patients

American journal of human genetics, 2003-05, Vol.72 (5), p.1288-1292

2003

Link zum Volltext

Verfügbarkeit prüfen

Ipsilateral Vestibular Schwannoma after Cochlear Implantation

Case reports in otolaryngology, 2022-02, Vol.2022, p.4918785-4

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and healthcare status of patients with neurofibromatosis type 1

British journal of dermatology (1951), 2011-07, Vol.165 (1), p.225-227

2011

Link zum Volltext

Verfügbarkeit prüfen

Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

Human mutation, 2008, Vol.29 (1), p.74-82

2008

Link zum Volltext

Verfügbarkeit prüfen

MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1

Neuroradiology, 2006-03, Vol.48 (3), p.160-165

2006

Link zum Volltext

Verfügbarkeit prüfen

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies

Gene therapy, 2001-03, Vol.8 (5), p.341-348

2001

Link zum Volltext

Verfügbarkeit prüfen

Mosaicism in Sporadic Neurofibromatosis 2 Patients

Human molecular genetics, 1998-12, Vol.7 (13), p.2051-2055

1998

Link zum Volltext

Verfügbarkeit prüfen

Spinal tumours in neurofibromatosis type 1 : an MRI study of frequency, multiplicity and variety

Neuroradiology, 1999-09, Vol.41 (9), p.625-629

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(261)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(191)
Humans
(163)
Life Sciences & Biomedicine
(163)
Biological And Medical Sciences
(101)
Male
(92)
Female
(87)
Medical Sciences
(82)
Adult
(79)
Adolescent
(60)
Neurology
(56)
Middle Aged
(53)
Child
(50)
Genetics & Heredity
(50)
Tumors Of The Nervous System. Phacomatoses
(45)
Fundamental And Applied Biological Sciences. Psychology
(37)
Neurosciences & Neurology
(36)
Animals
(35)
Magnetic Resonance Imaging
(33)
Aged
(30)
Clinical Neurology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation

Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

The putative oncogene CPI-17 is up-regulated in schwannoma

Growth in neurofibromatosis 1 microdeletion patients

Diagnostic criteria for schwannomatosis

High Frequency of Mosaicism among Patients with Neurofibromatosis Type 1 (NF1) with Microdeletions Caused by Somatic Recombination of the JJAZ1 Gene

Malignant Peripheral Nerve Sheath Tumors (MPNST) in NF1-affected Children

Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1

Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors

Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1)

Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas

High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1

Accumulation of non-compressive fascicular lesions underlies NF2 polyneuropathy

Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus

Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice

Cardiac characterization of 16 patients with large NF1 gene deletions

Elevated Risk for MPNST in NF1 Microdeletion Patients

Ipsilateral Vestibular Schwannoma after Cochlear Implantation

Clinical and healthcare status of patients with neurofibromatosis type 1

Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies

Mosaicism in Sporadic Neurofibromatosis 2 Patients

Spinal tumours in neurofibromatosis type 1 : an MRI study of frequency, multiplicity and variety

Suchergebnisse filtern